Positive recommendation based on phase II NOBILITY and phase III REGENCY data showing Gazyva/Gazyvaro’s superiority over standard therapy alone1,2Gazyva/Gazyvaro is the only anti-CD20 antibody to ...

In APPLAUSE-IgAN final analysis, Fabhalta demonstrated statistically significant, clinically meaningful improvement in estimated glomerular filtration rate (eGFR) slope vs. placebo over two years1eGFR ...

Positive recommendation based on phase II NOBILITY and phase III REGENCY data showing Gazyva/Gazyvaro's superiority over standard therapy alone1,2 Gazyva/Gazyvaro is the only anti-CD20 antibody to ...

Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year -- Second pivotal development ...

Omeros Corporation maintained with Strong Buy rating after securing a $2.1 billion partnership with Novo Nordisk for ...

Novo Nordisk's Alzheimer's trial really is like a lottery ticket. If it wins, the company gains a transformational new market ...

The FDA is issuing recalls of even more cannisters of a common kitchen spice, widening the scope to 16 brands.

Drug candidates spanning oncology, neurology, rare diseases and more are approaching critical development as the calendar turns to 2026.

In a recent report, Fichajes revealed that Barcelona are keeping a keen eye on Atletico Madrid midfielder Pablo Barrios. It ...

Kentucky basketball coach Mark Pope uses chess to bond with his players. But there’s also basketball benefits.

Liverpool’s Search for Rhythm and the Return of Alexis Mac AllisterA Squad Still Taking ShapeAfter seven Premier League games ...

This review explores how Cadmium (Cd), a toxic heavy metal can be used for eco-friendly remediation through multi-omics ...